Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. (Q48460262)
Jump to navigation
Jump to search
scientific article published on 30 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. |
scientific article published on 30 March 2012 |
Statements
1 reference
Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. (English)
1 reference
Maria Fleseriu
1 reference
Beverly M K Biller
1 reference
James W Findling
1 reference
Mark E Molitch
1 reference
David E Schteingart
1 reference
Coleman Gross
1 reference
SEISMIC Study Investigators
1 reference
30 March 2012
1 reference
97
1 reference
6
1 reference
2039-2049
1 reference
Identifiers
1 reference
1 reference